Drugs / Active Comparator vaccine
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07505836 Comparator | Mar 2026 → Jan 2027 expected | meningococcal meningitis | Sinovac Biotech Co., Ltd | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07505888 Comparator | Mar → Nov 2026 expected | meningitis, meningococcal infection | Sinovac Biotech Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | active comparator vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07505888 ↗ |
| Modality | Vaccine | “licensed ACYW135 meningococcal conjugate vaccine (CRM197 carrier)” NCT07505836 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT07505888 ↗ |